tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

July 19, 2012

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Resistant DepressionMoods DisordersUnipolar DepressionBipolar Disorder
Interventions
DEVICE

transcranial Direct Current Stimulation (tDCS) (Eldith DC NeuroConn Stimulator)

After locating the left DLPFC, ttt with active anodal tDCS with a current of 2 mA or sham over the left DLPFC will be directed by 30-minute session. Treatment will occur 2 sessions per day during 5 days per week. Subjects will be monitored during tDCS for any side effects or adverse events.

Trial Locations (6)

Unknown

CHRU Besancon - Service de Psychiatrie - Centre Investigation Clinique Innovation Technologique (CIC-IT808), Besançon

CHU Grenoble - Clinique de Psychiatrie de l'Adulte, Grenoble

CH Le Vinatier - Service de Psychiatrie, Lyon

Centre Hospitalier Guillaume Régnier - Rennes - Service Hospitalo-Universitaire de Psychiatrie, Rennes

Hôpital Civil de Strasbourg - Service de Psychiatrie, Strasbourg

Etablissement Public de Santé Mentale - Unité de Recherche Clinique, Ville Evrard

All Listed Sponsors
collaborator

Clinical Investigation Centre for Innovative Technology Network

NETWORK

collaborator

University Hospital, Grenoble

OTHER

collaborator

CH Le Vinatier - Service de Psychiatrie (Dr Emmanuel POULET)

UNKNOWN

collaborator

Rennes University Hospital

OTHER

collaborator

EPS Ville-Evrard - Unité de Recherche Clinique (Dr Dominique JANUEL)

UNKNOWN

collaborator

Hôpital Civil de Strasbourg - Service de Psychiatrie (Pr G.Bertschy)

UNKNOWN

lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT01644747 - tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients | Biotech Hunter | Biotech Hunter